Drugs / MYELOPEROXIDASE
MYELOPEROXIDASE
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT05342272 Comparator | Sep 2017 → Jan 2018 | — | Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia | Completed | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MYELOPEROXIDASE | ChEMBL registry synonym — accepted as the source's own label CHEMBL2107858 ↗ |
| Known as | Lactoperoxidase | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05342272 ↗ |
| Known as | MYELOPEROXIDASE COMPONENT OF E-101 | ChEMBL registry synonym — accepted as the source's own label CHEMBL2107858 ↗ |
| Known as | MYELOPEROXIDASE COMPONENT OF MPO; E-101 | ChEMBL registry synonym — accepted as the source's own label CHEMBL2107858 ↗ |
| Modality | Protein / enzyme biologic | — CHEMBL2107858 ↗ |